Mycophenolate mofetil for systemic lupus erythematosus refractory to other immunosuppressive agents.
about
Systematic review and meta-analysis of randomised trials and cohort studies of mycophenolate mofetil in lupus nephritisProspective, systematically recorded mycophenolate safety data in Graves' orbitopathy.Refractory immune thrombocytopenia in systemic lupus erythematosus: response to mycophenolate mofetil.Mycophenolate mofetil for non-renal manifestations of systemic lupus erythematosus: a systematic review.A randomized, blinded, parallel-group, pilot trial of mycophenolate mofetil (CellCept) compared with interferon beta-1a (Avonex) in patients with relapsing-remitting multiple sclerosis.A one-year prospective, randomized, placebo-controlled, quadruple-blinded, phase II safety pilot trial of combination therapy with interferon beta-1a and mycophenolate mofetil in early relapsing-remitting multiple sclerosis (TIME MS).Mycophenolate mofetil as maintenance therapy for proliferative lupus nephritis: a long-term observational prospective study.Treatment of severe proliferative lupus nephritis: the current state.Lupus nephritis: a review of the current pharmacological treatments.Mycophenolate mofetil in lupus nephritis.Novel therapies in lupus nephritis.Mycophenolate mofetil and systemic lupus erythematosus: an overview.Lupus nephritis: induction therapy.Joint European League Against Rheumatism and European Renal Association-European Dialysis and Transplant Association (EULAR/ERA-EDTA) recommendations for the management of adult and paediatric lupus nephritis.Basic immunosuppressive drugs outside solid organ transplantation.A multicentre, randomised controlled study of enteric-coated mycophenolate sodium for the treatment of relapsed or resistant proliferative lupus nephritis: an Asian experience.Systemic lupus erythematosus: pharmacological developments and recommendations for a therapeutic strategy.Novel approaches to therapy for systemic lupus erythematosus: update 2005.Current state of evidence on 'off-label' therapeutic options for systemic lupus erythematosus, including biological immunosuppressive agents, in Germany, Austria and Switzerland--a consensus report.Efficacy and safety of nonbiologic immunosuppressants in the treatment of nonrenal systemic lupus erythematosus: a systematic review.Rituximab and lupus--a promising pair?The multifaceted aspects of refractory lupus nephritis.Mycophenolate mofetil in the treatment of systemic lupus erythematosus.Long-term safety profile of belimumab plus standard therapy in patients with systemic lupus erythematosus.Open label randomized controlled trial assessing the efficacy of mycophenolate sodium against other conventional immunosuppressive agents in active systemic lupus erythematosus patients without renal involvement.Mycophenolate mofetil as a treatment for autoimmune haemolytic anaemia in patients with systemic lupus erythematosus and antiphospholipid syndrome.The NIH pulse cyclophosphamide regime: the end of an era?First international meeting on mycophenolate mofetil: an advance in the treatment of lupus 27 April 2004, St Thomas' Hospital, London, UK.Mycophenolate mofetil in multiple sclerosis: a multicentre retrospective study on 344 patients.Mycophenolate mofetil is effective in reducing disease flares in systemic lupus erythematosus patients: a retrospective study.Efficacy of enteric-coated mycophenolate sodium in patients with resistant-type lupus nephritis: a prospective study.Hypersensitivity to mycophenolate mofetil in systemic lupus erythematosus: diagnostic measures and successful desensitization.Mycophenolate mofetil for refractory haemolytic anemia in systemic lupus erythematosus.Somatostatin treatment attenuates proteinuria and prevents weight loss in NZB/W F1 mice.Effective plasma concentrations of mycophenolic acid and its glucuronide in systemic lupus erythematosus patients in the remission-maintenance phase.Switching treatment between mycophenolate mofetil and azathioprine in lupus patients: indications and outcomes.
P2860
Q21195423-1AF2D0C1-A95A-41A5-A783-CC631BFC9328Q31047067-D77CE023-3227-4518-A622-EEC172AF7F66Q33349723-79607EFC-3D8D-4B6A-B77D-A258651C2162Q33377162-C7A80675-1C0F-450F-8589-614C06AAEAAFQ34409297-8559DE97-C7CA-45B9-8EE1-ED44721E90BCQ34409308-3BF85F3F-E9D3-41B4-A00C-8B6F0A2FE702Q34613945-D082947C-BE50-46F5-9A0D-BAAA378CD4B8Q35201234-BDB51F49-F0A0-41F4-90A4-CC763AC2F425Q35925513-0698DD1A-30B0-474F-ACE1-AD9E535113AFQ36054863-616112C6-E249-4E97-AC17-639F45FB7489Q36054877-EE351B6D-2DE5-4FDE-985A-016A074CFDA1Q36085845-FDD516D6-5236-4A4B-8046-79DED3C7145BQ36085856-262185A0-211D-4F6E-BE13-95DB0C8923DFQ36302245-026FB7E0-5D17-4222-A026-4A2A85D17F65Q36407314-5B3A6CF2-5694-4085-8656-EF299D13B2AFQ36472649-939F1B21-B023-40BB-A568-3297B8A661D6Q37038984-065B680E-28B0-404D-A517-A20B6F64994AQ37754557-4BC0ED24-D5B8-4642-B1D1-E26503D0DD77Q37954539-F3FAEEF8-6D2D-4695-A2B0-BEBB715539ABQ38101015-8225980D-EF73-4684-9874-DE93D9F8DCFFQ38235185-14BE29AB-CE65-4381-96B2-FF0656AA7E4BQ38285375-3F7C2DF2-F8F2-466E-9771-7C4C91697197Q38327763-BA4577C7-C62F-402F-B480-AFFE0B55DD33Q42652135-E3A9BF71-B8C8-4CDF-9463-15C86DD7924CQ43970142-B3C27946-1B68-4E19-B5B8-A8B91950DBB6Q44566697-55BC26B5-FE32-43F8-9046-017E00EA0152Q44761101-955A6F14-622E-4035-9010-3A54CB7EF9F0Q45047982-30C5B3E9-8E92-405C-9FDF-BB9C3C9A1AC4Q45113442-CC950245-2FDF-4E8C-9C25-352D6C6D0BAAQ46076332-EB0BC1B2-DB69-4F4C-A4A3-75B8AD6A14E8Q46484861-038487CE-F2E8-4F9B-9DE0-D433C3F8AE97Q46752248-5F5FED94-39C5-42C7-AD03-48FFD8CB18BBQ46815725-614ECBE4-4E9F-462D-A006-3C9E1DB88550Q47323437-445E0B1F-3DC3-49AA-9F7E-53B594F21A64Q50539103-3E5CCC2C-A145-4A8E-86C4-6BD1D6DCC23CQ50687031-65187ABE-0A3A-4E42-A0F1-1F75AB2DA3FB
P2860
Mycophenolate mofetil for systemic lupus erythematosus refractory to other immunosuppressive agents.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
2002年學術文章
@zh-hant
name
Mycophenolate mofetil for syst ...... ther immunosuppressive agents.
@en
Mycophenolate mofetil for syst ...... ther immunosuppressive agents.
@nl
type
label
Mycophenolate mofetil for syst ...... ther immunosuppressive agents.
@en
Mycophenolate mofetil for syst ...... ther immunosuppressive agents.
@nl
prefLabel
Mycophenolate mofetil for syst ...... ther immunosuppressive agents.
@en
Mycophenolate mofetil for syst ...... ther immunosuppressive agents.
@nl
P2093
P356
P1433
P1476
Mycophenolate mofetil for syst ...... ther immunosuppressive agents.
@en
P2093
P304
P356
10.1093/RHEUMATOLOGY/41.8.876
P577
2002-08-01T00:00:00Z